Global and China Gastrointestinal Stromal Tumor (GIST) Drug Market Insights, Forecast to 2026

Market Analysis and Insights: Global and China Gastrointestinal Stromal Tumor (GIST) Drug Market
This report focuses on global and China Gastrointestinal Stromal Tumor (GIST) Drug QYR Global and China market.
The global Gastrointestinal Stromal Tumor (GIST) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Gastrointestinal Stromal Tumor (GIST) Drug Scope and Market Size
Gastrointestinal Stromal Tumor (GIST) Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal Stromal Tumor (GIST) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Gastrointestinal Stromal Tumor (GIST) Drug market is segmented into
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others

Segment by Application, the Gastrointestinal Stromal Tumor (GIST) Drug market is segmented into
Clinic
Hospital
Others

Regional and Country-level Analysis
The Gastrointestinal Stromal Tumor (GIST) Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Gastrointestinal Stromal Tumor (GIST) Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape

and Gastrointestinal Stromal Tumor (GIST) Drug Market Share Analysis
Gastrointestinal Stromal Tumor (GIST) Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gastrointestinal Stromal Tumor (GIST) Drug business, the date to enter into the Gastrointestinal Stromal Tumor (GIST) Drug market, Gastrointestinal Stromal Tumor (GIST) Drug product introduction, recent developments, etc.
The major vendors covered:
Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation

Frequently Asked Questions